Brief: InDex Pharmaceuticals To Carry Out Rights Issue Of About SEK 500 Mln
Nov 25 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* INDEX PHARMACEUTICALS INTENDS TO CARRY OUT A FULLY
GUARANTEED
RIGHTS ISSUE OF APPROXIMATELY SEK 500 MILLION TO FUND PHASE III
DEVELOPMENT OF COBITOLIMOD
* NET PROCEEDS ARE TO BE USED TO FUND IMPORTANT INITIAL
INDUCTION
STUDY IN A SEQUENTIAL PHASE III PROGRAM
Source text for Eikon: ID:nWkr9Kbpn4
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen